MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STERN, P. H.
Right arrow Articles by DELUCA, H. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STERN, P. H.
Right arrow Articles by DELUCA, H. F.

Molecular Pharmacology, Vol 14, 357-365, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Responses of Fetal Rat Bones to Solanum malacoxylon in Vitro: a Possible Explanation of Previous Paradoxical Results

PAULA H. STERN 1, EARL M. NESS 1, and HECTOR F. DELUCA 2

1 Department of Pharmacology, Northwestern University, Chicago, Illinois 60611
2 Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706

A partially purified extract of Solanum malacoxylon was tested for its actions on fetal rat bone in vitro. The extract had a biphasic effect on bone resorption in vitro, stimulating at low concentrations (0.3-0.3 mg/ml) and inhibiting at concentrations of 1 mg/ml and higher. The stimulatory effect could be antagonized with calcitonin or glucagon. At a concentration of 1.0 mg/ml, the S. malacoxylon extract antagonized the bone-resorbing effects of lagr,25-dihydroxyvitamin D3[1,25-(OH)2D3] and parathyroid hormone. To determine whether effects in vitro could be due to 1,25-(OH)2D3 released into the medium during incubation, bones were cultured with equieffective concentrations of parathyroid hormone, 1,25-(OH)2D3, or S. malacoxylon, and the culture medium was extracted with organic solvents. Chloroform or benzene extracts from control or parathyroid hormone treated cultures were inactive, whereas those from 1,25-(OH)2D3-treated cultures retained most or all of the activity of the original media. Benzene extracts of S. malacoxylon culture, media inhibited resorption. The inhibitory material could be removed by high-pressure liquid chromatography, but the benzene extract was still ineffective. The results would be consistent with S. malacoxylon acting in vitro as the unhydrolyzed glycoside conjugate. However, it is also possible that the bone cells hydrolyze the glycoside to release small amounts of 1,25-(OH)2D3, which then interacts with the receptor.

Note:
ACKNOWLEDGMENTS We would like to express our appreciation to Jan Miller and Thalia Mavreas for their excellent technical assistance, and to Lorraine Reeve and Michael Holick for providing the S. malacoxylon extract used in these studies.

Submitted on June 14, 1977
Accepted on November 16, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics